Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. Facing Critical Hospital Bed Shortage
US News and World Report
Thursday, February 20, 2025 - 5:43pm
tags:
hospitals, Public Health
Roche unveils its breakthrough proprietary SBX sequencing technology
Tip Ranks
Thursday, February 20, 2025 - 5:39pm
tags:
Roche, Medtech, DNA sequencing, SBX sequencing
US biotech Hookipa retracts merger plans with UK company
Fierce Biotech
Thursday, February 20, 2025 - 5:36pm
tags:
Hookipa Pharma, M&A, Poolbeg Pharma
AstraZeneca deepens China presence with FibroGen deal
BioPharma Dive
Thursday, February 20, 2025 - 11:52am
tags:
AstraZeneca, FDA, FibroGen, China, roxadustat
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
Clinical Trials Arena
Thursday, February 20, 2025 - 11:51am
tags:
Precision Biosciences, clinical trials, hepatitis B, PBGENE-HBV, gene editing
Trump administration yanks CDC flu vaccine campaign
NPR
Thursday, February 20, 2025 - 11:49am
tags:
Donald Trump, vaccines, CDC, Flu
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars
Yahoo Finance
Thursday, February 20, 2025 - 11:40am
tags:
Baxter International, Medtech, earnings
Bristol Myers Squibb notches overall survival win with Opdivo in preoperative NSCLC
Fierce Pharma
Thursday, February 20, 2025 - 11:38am
tags:
Bristol Myers Squibb, Opdivo, non-small cell lung cancer, clinical trials
Insurers push back on Medicare and Medicaid coverage for GLP-1s
Axios
Thursday, February 20, 2025 - 11:37am
tags:
insurers, Medicare, Medicaid, obesity, Novo Nordisk, Eli Lilly, Mounjaro, Wegovy
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
Pharma Voice
Thursday, February 20, 2025 - 11:35am
tags:
Immunocore, Travis Coy, Eli Lilly, M&A
BridgeBio’s heart drug launch gets off to a fast start
BioPharma Dive
Thursday, February 20, 2025 - 11:34am
tags:
BridgeBio, Attruby, Pfizer, tafamidis, transthyretin amyloidosis cardiomyopathy
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Clinical Trials Arena
Thursday, February 20, 2025 - 11:33am
tags:
layoffs, FDA, CDC, NIH, DOGE
Boehringer eyes third quarter FDA verdict for oral HER2 drug
Pharmaphorum
Thursday, February 20, 2025 - 11:29am
tags:
Boehringer Ingelheim, zongertinib, FDA, metastatic non-small cell lung cancer
SMA treatment with Evrysdi 'could start prenatally'
Pharmaphorum
Thursday, February 20, 2025 - 11:27am
tags:
Roche, Evrysdi, SMA
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
CNBC
Thursday, February 20, 2025 - 11:25am
tags:
Hims & Hers Health, M&A, Trybe Labs, diagnostics, Medtech
Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants
Fierce Pharma
Wednesday, February 19, 2025 - 9:52pm
tags:
Novartis, Roche, Vas Narasimhan, Thomas Schinecker, executive pay
Recursion CEO launches pre-seed fund in response to NIH cuts
BioPharma Dive
Wednesday, February 19, 2025 - 9:51pm
tags:
Recursion, Altitude Labs, R&D, funding, NIH, Chris Gibson
FTC retains stricter merger guidelines under Trump
BioPharma Dive
Wednesday, February 19, 2025 - 9:49pm
tags:
FTC, M&A, Donald Trump
Ascletis' swift surge into obesity continues with competitive oral GLP-1 data
Fierce Biotech
Wednesday, February 19, 2025 - 9:47pm
tags:
Ascletis Pharma, obesity, clinical trials, ASC30
Trump to meet pharma leaders as they seek drug policy changes
Investing.com
Wednesday, February 19, 2025 - 9:44pm
tags:
Donald Trump, Pharma CEPs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.